Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer ...
Ivantis Inc. in Irvine closed on a $25 million Series C funding round for development and eventual marketing of a stent intended for use in glaucoma surgery. New investor RA Capital Management LLC in ...
On a hilltop overlooking Camp Pendleton, some of the world’s smallest medical devices are being made. About 225 employees of Glaukos Corp. (NYSE: GKOS) peer into microscopes, constructing daily ...
NEW YORK (CBS.MW) -- Upcoming results, good or bad, from European trials of Boston Scientific's new drug-coated stent are likely to set the tone for the company's shares, according to Barron's. Stents ...
ZURICH, Aug 29 (Reuters) - Novartis eye care unit Alcon is voluntarily withdrawing its CyPass Micro-Stent after follow-up clinical data showed patients using the product experienced statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results